Caimmi Silvia, Crisafulli Giuseppe, Franceschini Fabrizio, Liotti Lucia, Bianchi Annamaria, Bottau Paolo, Mori Francesca, Triggiano Paolo, Paglialunga Claudia, Saretta Francesca, Giannetti Arianna, Ricci Giampaolo, Caffarelli Carlo
UOC Pediatria, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
UOC Pediatria, Università di Messina, 98124 Messina, Italy.
Children (Basel). 2022 Sep 27;9(10):1473. doi: 10.3390/children9101473.
Intravenous iron is widely used for the treatment of iron deficiency anemia when adherence to oral iron replacement is poor. Acute hypersensitivity reactions during iron infusions are very rare but can be life threatening. Major risk factors for hypersensitivity reactions include a previous reaction to an iron infusion, a fast iron infusion rate, multiple drug allergies, atopic diseases, high serum tryptase levels, asthma, and urticaria. The management of iron infusions requires meticulous observation, and, in the event of an adverse reaction, prompt recognition and severity-related interventions by well-trained medical and nursing staff. Avoidance of IV iron products in patients with iron hypersensitivity reactions may not be considered as a standard practice.
当口服铁剂补充治疗的依从性较差时,静脉铁剂被广泛用于治疗缺铁性贫血。铁剂输注过程中的急性过敏反应非常罕见,但可能危及生命。过敏反应的主要危险因素包括既往对铁剂输注有反应、铁剂输注速度过快、多种药物过敏、特应性疾病、血清类胰蛋白酶水平升高、哮喘和荨麻疹。铁剂输注的管理需要细致观察,一旦发生不良反应,训练有素的医护人员要能迅速识别并采取与严重程度相关的干预措施。对于有铁过敏反应的患者,不将避免使用静脉铁剂产品视为标准做法。